Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 23;12(3):433-436.
doi: 10.1093/ckj/sfy062. eCollection 2019 Jun.

Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients?

Affiliations

Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients?

Jacques Rottembourg et al. Clin Kidney J. .

Abstract

Parathyroid glands consist primarily of chief cells. In some cases, the proportion of parathyroid oxyphil cells increases in patients with chronic kidney disease. We describe a case of secondary hyperparathyroidism (SHPT) in a patient treated with haemodialysis who initially received large doses of vitamin D and calcium (Ca) supplements, as well as high doses of cinacalcet hydrochloride (C-HCl), but without any effect on parathyroid hormone levels. Following a successful parathyroidectomy, histopathological examination revealed that two of the parathyroid glands consisted of 40% of oxyphil cells. Oxyphil cells have significantly more Ca-sensing receptors (CaSRs) than chief cells, suggesting that CaSRs are involved in the transdifferentiation of chief cells to oxyphil cells. C-HCl treatment leads to a significant increase in parathyroid oxyphil cell content. This case suggests that C-HCl may induce specific phenotypic alterations in hyperplastic parathyroid glands in patients with severe SHPT.

Keywords: calcimimetic; calcium-sensing receptor; chronic kidney disease; haemodialysis; secondary hyperparathyroidism.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
(A) The chief cells have an amphophilic, vacuolated cytoplasm. (B) The oxyphil cells are composed of large cells with a brightly stained eosinophilic granular cytoplasm. The bar at the bottom represents 1 mm (magnitude ×100).

Similar articles

Cited by

References

    1. Chertow GM, Plone M, Dillon MA. et al. Hyperparathyroidism and dialysis vintage. Clin Nephrol 2000; 54: 295–300 - PubMed
    1. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(4 Suppl 3): S1–S201 - PubMed
    1. Ketteler M, Block GA, Evenepoel P. et al. Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int 2017; 92: 26–36 - PubMed
    1. Urena P, Frazao JM.. Calcimimetic agents: review and perspectives. Kidney Int 2003; 63(Suppl 85): S91–S96 - PubMed
    1. Urena P, Fouque D, Brunet P. et al. Cinacalcet treatment for secondary hyperparathyroidism in dialysis patients in real-world clinical practice – the ECHO observational study: French experience. Nephrol Ther 2012; 8: 527–533 - PubMed